Artificial Intelligence & Data
Glyphic Biotechnologies
United Statesglyphic.bio/
Glyphic Biotechnologies is an Artificial Intelligence & Data startup based in the United States, most recent round Series A, 4 tracked investors.
activeseries-a
series-a
Stage
2021
Founded
4
Investors
About Glyphic Biotechnologies
Glyphic Biotechnologies is a startup founded in 2021 based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Artificial Intelligence & Data. Brouky records 4 investors associated with the company.
Glyphic Biotechnologies develops a de novo high-throughput proteome sequencing technology called Protein Sequencing by Expansion (ProSE™), enabling accurate single molecule discrimination of all 20 amino acids and post-translational modifications.
Explore Glyphic Biotechnologies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.